|
LO-1
|
Will be able to define the components of the immune system. |
|
LO-2
|
Will be able to define the components of the endocrine system. |
|
LO-3
|
Will be able to define the components of the digestive system. |
|
LO-4
|
Will be able to define the accessory digestive glands. |
|
LO-5
|
Will be able to explain general physiological concepts related to the immune system. |
|
LO-6
|
Will be able to explain general physiological concepts related to the physiology of the endocrine system. |
|
LO-7
|
Will be able to define hypothalamic hormones. |
|
LO-8
|
Will be able to define pituitary hormones. |
|
LO-9
|
Will be able to define thyroid hormones. |
|
LO-10
|
Will be able to define parathyroid hormone, vitamin D, and calcitonin. |
|
LO-11
|
Will be able to define pancreatic hormones. |
|
LO-12
|
Will be able to define adrenal cortex hormones (glucocorticoids, mineralocorticoids). |
|
LO-13
|
Will be able to define sex steroids. |
|
LO-14
|
Will be able to explain the general principles of gastrointestinal function—motility, neural control, and blood circulation. |
|
LO-15
|
Will be able to explain the movement and mixing of food in the digestive tract. |
|
LO-16
|
Will be able to explain the secretory functions of the digestive tract. |
|
LO-17
|
Will be able to explain digestion and absorption in the gastrointestinal tract. |
|
LO-18
|
Will be able to explain the physiology of gastrointestinal disorders. |
|
LO-19
|
Will be able to explain the liver as an organ. |
|
LO-20
|
Will be able to explain immunosuppressive drugs. |
|
LO-21
|
Will be able to explain immunostimulant drugs. |
|
LO-22
|
Will be able to explain antiallergic drugs. |
|
LO-23
|
Will be able to explain hypothalamic and pituitary hormone drugs. |
|
LO-24
|
Will be able to explain thyroid hormone preparations and antithyroid drugs. |
|
LO-25
|
Will be able to explain parathyroid hormone and vitamin D preparations, and calciotropic drugs. |
|
LO-26
|
Will be able to explain insulin-glucagon analogs and antidiabetic drugs. |
|
LO-27
|
Will be able to explain corticosteroids, corticosteroid antagonists, and ACTH. |
|
LO-28
|
Will be able to explain estrogens, progestins, and their antagonists. |
|
LO-29
|
Will be able to explain androgens, anabolic steroids, and antiandrogenic drugs. |
|
LO-30
|
Will be able to explain the drugs used in the treatment of peptic ulcers. |
|
LO-31
|
Will be able to explain laxative and purgative drugs. |
|
LO-32
|
Will be able to explain antidiarrheal drugs. |
|
LO-33
|
Will be able to explain emetic, antiemetic, and prokinetic drugs. |
|
LO-34
|
Will be able to explain other drugs that affect the digestive system. |
|
LO-35
|
Will be able to define the adverse effects induced by immunosuppressive drugs. |
|
LO-36
|
Will be able to explain the adverse effects induced by immunostimulant drugs. |
|
LO-37
|
Will be able to explain the adverse effects induced by thyroid hormone preparations and antithyroid drugs. |
|
LO-38
|
Will be able to define the adverse effects induced by parathyroid hormone and vitamin D preparations, as well as calciotropic drugs. |
|
LO-39
|
Will be able to define the adverse effects induced by insulin-glucagon analogs and antidiabetic drugs. |
|
LO-40
|
Will be able to define the adverse effects induced by corticosteroids, corticosteroid antagonists, and ACTH. |
|
LO-41
|
Explains the adverse effects induced by estrogens, progestins, and their antagonists. |
|
LO-42
|
Will be able to explain the adverse effects induced by androgens, anabolic steroids, and antiandrogenic drugs. |
|
LO-43
|
Will be able to explain the adverse effects induced by drugs used in the treatment of peptic ulcers. |
|
LO-44
|
Will be able to explain the adverse effects induced by laxatives and purgatives. |
|
LO-45
|
Will be able to define the adverse effects induced by antidiarrheal drugs. |
|
LO-46
|
Will be able to identify adverse effects induced by emetic, antiemetic, and prokinetic drugs. |
|
LO-47
|
Will be able to define the adverse effects induced by other drugs affecting the digestive system. |